Skip to content
Disclosery

Harpswell Capital Advisors, LLC: CATH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Harpswell Capital Advisors, LLC on CATH, newest first. How the timeline and the estimate are built.

Harpswell Capital Advisors, LLC held 0 CATH shares at 2026-09-30 per its 13F-HR filed 2026-10-09.

the latest 13F is the newest step

  1. period ended2026-09-30
    13F 0 shares
    Change vs previous 13F -20,000 shares

    13F-HR 0001806630-26-000004 filed by Harpswell Capital Advisors, LLC
    Accepted , ingested

    Exited: the 13F for this period no longer lists the position.

  2. period ended2026-06-30
    13F 20,000 shares
    Change vs previous 13F -2,772 shares

    1.14% of the 13F portfolio, value $1,770,000.

    13F-HR 0001806630-26-000003 filed by Harpswell Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2026-03-31
    13F 22,772 shares
    Change vs previous 13F 0 shares

    1.33% of the 13F portfolio, value $1,779,632.

    13F-HR 0001806630-26-000002 filed by Harpswell Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-12-31
    13F 22,772 shares
    Change vs previous 13F 0 shares

    1.48% of the 13F portfolio, value $1,872,466.

    13F-HR 0001806630-26-000001 filed by Harpswell Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-09-30
    13F 22,772 shares
    Change vs previous 13F not available

    1.76% of the 13F portfolio, value $1,845,864.

    13F-HR 0001806630-25-000003 filed by Harpswell Capital Advisors, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).